Shares of Amarin Corporation AMRN rose 7.1% on Wednesday after management announced positive updates on its intellectual property portfolio for its sole marketed drug, Vazkepa, in Europe. Amarin ...

DUBLIN, Ireland and BRIDGEWATER, N.J., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced its participation in the 42 nd Annual JP Morgan Healthcare Conference.

June 17 (Reuters) - Drugmaker Apotex has sued its rival Amarin <AMRN.O> in federal court in New Jersey, accusing it of thwarting competition for a generic version of its heart drug Vascepa and causing ...

GREENWICH, Conn.--(BUSINESS WIRE)--Sarissa Capital Management LP (“Sarissa”) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN): Sarissa urges Amarin shareholders to ...

SAN DIEGO--(BUSINESS WIRE)--Robbins Geller Rudman & Dowd LLP announces that purchasers of Amarin Corporation plc (NASDAQ: AMRN) securities between December 5, 2018 and June 21, 2021, inclusive (the ...

In the midst of Amarin’s activist investor blowout with Sarissa Capital Management, the company has a new battle brewing. In a new antitrust suit, generics maker Hikma has accused Amarin of ...

Amarin Corporation PLC (NASDAQ:AMRN) shares jumped 11% following the announcement of an exclusive long-term licensing and supply agreement with Italian pharmaceutical company Recordati S.p.A. (BIT: ...

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals Dr. Reddy's filed similar lawsuit in 2021 (Reuters) - Generic drugmaker Hikma Pharmaceuticals USA Inc has sued ...

Amarin (AMRN) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the ...

Amarin (AMRN) shares rallied 27.3% in the last trading session to close at $16.04. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session ...